Drug profile · INN
pemetrexed disodium
PEMETREXED DISODIUM
pemetrexed disodium (PEMETREXED DISODIUM) is a thymidylate synthase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — pemetrexed disodium
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 1
- Programs
- 27
- Data quality
- 0.89
Quick answer
pemetrexed disodium (PEMETREXED DISODIUM) is a thymidylate synthase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Thymidylate synthase inhibitor
Primary target: Dihydrofolate reductase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is pemetrexed disodium?
pemetrexed disodium (PEMETREXED DISODIUM) is a thymidylate synthase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for pemetrexed disodium?
PEMETREXED DISODIUM is a marketed brand name for pemetrexed disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pemetrexed disodium?
pemetrexed disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.